Recombinant Thrombomodulin Has an Antitumor Effect and Enhances the Sensitivity of Gemcitabine Treatment of Pancreatic Cancer via G-protein Coupled Receptor 15

Authors

• Kenei Furukawa, The Jikei University School of MedicineFollow
• Jianhua Ling, The University of Texas MD Anderson Cancer Center
• Yichen Sun, The University of Texas MD Anderson Cancer Center
• Yu Lu, The University of Texas MD Anderson Cancer Center
• Nathan Nguyen, The University of Texas MD Anderson Cancer Center
• Pranavi Garlapati, The University of Texas MD Anderson Cancer Center
• Paul J. Chiao, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

Recombinant Thrombomodulin; Gemcitabine; GPR15; Pancreatic Cancer

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

High School Summer Program

Recommended Citation

Furukawa, Kenei; Ling, Jianhua; Sun, Yichen; Lu, Yu; Nguyen, Nathan; Garlapati, Pranavi; and Chiao, Paul J., "Recombinant Thrombomodulin Has an Antitumor Effect and Enhances the Sensitivity of Gemcitabine Treatment of Pancreatic Cancer via G-protein Coupled Receptor 15" (2021). Summer Experience 2021. 217.
https://openworks.mdanderson.org/sumexp21/217